(SYBX) – FDA
-
Synlogic (SYBX) to Discontinue Synpheny-3 Study and Provides Corporate Update
-
Synlogic (SYBX) Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SYBX Stock Lookup